Dag-uman, Ashley Joy M.
HRN: 26-31-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/30/2024
12/06/2024
IV
50mg
Q8
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes